Regeneron (REGN) and Sanofi's (SNY) Sarilumab Approved in Canada for Adult Patients with Moderately to Severely Active Rheumatoid Arthritis (RA)

Source Link:

http://www.prnewswire.com/news-releases/regeneron-and-sanofi-announce-first-approval-of-kevzara-sarilumab-for-the-treatment-of-moderately-to-severely-active-rheumatoid-arthritis-in-adult-patients-by-health-canada-300400106.html